YD Bio Ltd SEC filings YDES
YD Bio Ltd has 80 filings in SEC EDGAR's recent list, going back to Feb 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 1, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 29, 2026 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| 20FR12B | Registration statement | Sep 5, 2025 | — |
| CERT | Filing | Aug 28, 2025 | — |
| 8-A12B | For registration of certain classes | Aug 20, 2025 | — |
| EFFECT | Filing | Jul 18, 2025 | — |
| CORRESP | Letter to the SEC | Jul 16, 2025 | — |
| CORRESP | Letter to the SEC | Jul 10, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2025 | — |
| CORRESP | Letter to the SEC | Jun 30, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 4, 2025 | — |
| UPLOAD | Letter from the SEC | May 15, 2025 | — |
| CORRESP | Letter to the SEC | Apr 30, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2025 | — |
| CORRESP | Letter to the SEC | Mar 17, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2025 | — |
| CORRESP | Letter to the SEC | Jan 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2025 | — |
| SEC STAFF ACTION | Filing | Jan 13, 2025 | — |
| 425 | Form 425 | Jun 21, 2024 | — |
| 425 | Form 425 | Mar 21, 2024 | — |
| 425 | Form 425 | Mar 15, 2024 | — |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- YDES (Nasdaq), YDESW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Taipei City
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2011674
- Former names
- True Velocity, Inc./DE (until Jun 21, 2024)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.